LIAONING CHENGDA BIOTECHNOLOGY CO L revenue breakdown overview

LIAONING CHENGDA BIOTECHNOLOGY CO L revenue for the last year amounted to 1.68 B CNY, the most of which — 1.54 B CNY — came from its highest performing source at the moment, Human Rabies Vaccine, the year earlier bringing 1.64 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought LIAONING CHENGDA BIOTECHNOLOGY CO L 1.48 B CNY, and the year before that — 1.62 B CNY.